title: [Telaprevir-induced pityriasis rubra pilaris].
authors.affiliation: Service de dermatologie, hôpitaux de Brabois, 6, rue du Morvan, 54511 Vandoeuvre-lès-Nancy, France. jl.schmutz@chu-nancy.fr
authors.forename: J-L
authors.initials: JL
authors.lastname: Schmutz
authors.forename: P
authors.initials: P
authors.lastname: Trechot
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D000998:Antiviral Agents / Q000008:administration & dosage / Q000627:therapeutic use; D001706:Biopsy; D003875:Drug Eruptions / Q000188:drug therapy / Q000209:etiology* / Q000473:pathology; D004359:Drug Therapy, Combination; D004802:Eosinophilia / Q000209:etiology; D004804:Eosinophils / Q000473:pathology; D016174:Hepacivirus / Q000187:drug effects / Q000201:enzymology; D019698:Hepatitis C, Chronic / Q000188:drug therapy / Q000821:virology; D006633:Histamine Antagonists / Q000627:therapeutic use; D006801:Humans; D016898:Interferon-alpha / Q000008:administration & dosage / Q000627:therapeutic use; D015603:Keratinocytes / Q000473:pathology; D008214:Lymphocytes / Q000473:pathology; D008875:Middle Aged; D009842:Oligopeptides / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D010916:Pityriasis Rubra Pilaris / Q000139:chemically induced* / Q000188:drug therapy / Q000473:pathology; D011092:Polyethylene Glycols / Q000008:administration & dosage / Q000627:therapeutic use; D011480:Protease Inhibitors / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000627:therapeutic use; D012254:Ribavirin / Q000008:administration & dosage / Q000627:therapeutic use; D012867:Skin / Q000473:pathology; D017361:Viral Nonstructural Proteins / Q000037:antagonists & inhibitors; D012697:Serine Endopeptidases; D043583:Nucleoside-Triphosphatase; D053487:DEAD-box RNA Helicases; D000085242:Viral Proteases
chemical_list: D000305:Adrenal Cortex Hormones; D000998:Antiviral Agents; D006633:Histamine Antagonists; D016898:Interferon-alpha; D009842:Oligopeptides; D011092:Polyethylene Glycols; D011480:Protease Inhibitors; D011994:Recombinant Proteins; D012254:Ribavirin; D017361:Viral Nonstructural Proteins; C084422:NS3 protein, hepatitis C virus; D012697:Serine Endopeptidases; D043583:Nucleoside-Triphosphatase; D053487:DEAD-box RNA Helicases; D000085242:Viral Proteases; C486464:telaprevir; C100416:peginterferon alfa-2a